Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?

Circulation. 2026 Jan 27;153(4):226-229. doi: 10.1161/CIRCULATIONAHA.125.078276. Epub 2026 Jan 26.

Authors

Michel G Khouri¹, Jan M Griffin²

Affiliations

¹ Department of Medicine, Duke University Hospital System, Durham, NC (M.G.K.).
² Department of Medicine, Medical University of South Carolina, Charleston, SC (J.M.G.).

PMID: 41587274
DOI: 10.1161/CIRCULATIONAHA.125.078276

No abstract available

Keywords: Editorials; amyloidosis; cardiomyopathies; clinical study; heart failure; prealbumin.

Publication types

Editorial
Comment